Last reviewed · How we verify
Single Shot Femoral Nerve Blocks
Single Shot Femoral Nerve Blocks is a Small molecule drug developed by Eastern Maine Medical Center. It is currently in Phase 1 development. Also known as: 0.5% ropivacaine.
At a glance
| Generic name | Single Shot Femoral Nerve Blocks |
|---|---|
| Also known as | 0.5% ropivacaine |
| Sponsor | Eastern Maine Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- From Battlefield to Recovery: Continuous Regional Anaesthesia for War-Related Lower Limb Trauma
- Pain Relief Comparison: Pericapsular Nerve Group Versus Quadratus Lumborum Block for Positioning in Femur Fracture Surgery (NA)
- Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach (NA)
- Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty (PHASE4)
- Peripheral Nerve Blocks for Above-the-knee Amputations (PHASE4)
- Ultrasound-Guided PASC Block vs Femoral-Sciatic Nerve Block for Postoperative Analgesia After Total Knee Arthroplasty (NA)
- Comparison of the Efficiency of Femur Nerve Block and Intravenous Analgesia Treatment in Hip Fracture Patients (PHASE4)
- Effect of iPACK and BiFeS Blocks on Quality of Recovery After Total Knee Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single Shot Femoral Nerve Blocks CI brief — competitive landscape report
- Single Shot Femoral Nerve Blocks updates RSS · CI watch RSS
- Eastern Maine Medical Center portfolio CI
Frequently asked questions about Single Shot Femoral Nerve Blocks
What is Single Shot Femoral Nerve Blocks?
Single Shot Femoral Nerve Blocks is a Small molecule drug developed by Eastern Maine Medical Center.
Who makes Single Shot Femoral Nerve Blocks?
Single Shot Femoral Nerve Blocks is developed by Eastern Maine Medical Center (see full Eastern Maine Medical Center pipeline at /company/eastern-maine-medical-center).
Is Single Shot Femoral Nerve Blocks also known as anything else?
Single Shot Femoral Nerve Blocks is also known as 0.5% ropivacaine.
What development phase is Single Shot Femoral Nerve Blocks in?
Single Shot Femoral Nerve Blocks is in Phase 1.
Related
- Manufacturer: Eastern Maine Medical Center — full pipeline
- Also known as: 0.5% ropivacaine
- Compare: Single Shot Femoral Nerve Blocks vs similar drugs
- Pricing: Single Shot Femoral Nerve Blocks cost, discount & access